...
首页> 外文期刊>BMC research notes >Comparative-effectiveness of vancomycin and linezolid as part of guideline-recommended empiric therapy for healthcare-associated pneumonia
【24h】

Comparative-effectiveness of vancomycin and linezolid as part of guideline-recommended empiric therapy for healthcare-associated pneumonia

机译:万古霉素和利奈唑胺作为指南推荐的经验性治疗对医疗保健相关性肺炎的疗效比较

获取原文
           

摘要

Background Linezolid has been directly compared to vancomycin in pneumonia; however, most clinical trials have not compared outcomes specifically in the healthcare-associated pneumonia (HCAP) population. The objective of this study was to compare the effectiveness of vancomycin and linezolid in a national cohort of hospitalized veterans with HCAP.
机译:背景在肺炎中,利奈唑胺已直接与万古霉素进行了比较。但是,大多数临床试验并未在医疗保健相关性肺炎(HCAP)人群中比较结果。这项研究的目的是比较万古霉素和利奈唑胺在全国住院的HCAP退伍军人队列中的有效性。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号